An observational, prospective, multinational, multicentre study comparing the effectiveness of safinamide, rasagiline and other “standard of care” as add-on therapy to levodopa (L-dopa) in Parkinson’s Disease (PD) fluctuating patients
Public Engagement To evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality of life of PD patients by means of the Parkinson’s Disease Questionnaire (PDQ)-39 items.